Journal
LEUKEMIA & LYMPHOMA
Volume 61, Issue 1, Pages 128-137Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10428194.2019.1658098
Keywords
Chronic myelogenous leukemia (CML); myeloid-derived suppressor cells (MDSCs); microvesicles (MVs); treatment-free remission (TFR)
Categories
Funding
- National Natural Science Foundation of China [81700142]
Ask authors/readers for more resources
Myeloid-derived suppressor cells (MDSCs) are considered to be a strong contributor to the immunosuppressive tumor microenvironment. In our study, the counts of MDSCs were correlated with the remission status of CML patients, especially the M-MDSCs. M-MDSCs promoted the proliferation of K562 cells or CD34+ cells from newly diagnosed CML patients, no matter in cells or mice experiments. We also established a TKI discontinuation model using the K562 cell line for examining the effect of microvesicles (MVs) derived from K562 cells before and after TKI discontinuation on MDSCs. We found a mutual promotion of proliferation of tumor cells and MDSCs. Moreover, MVs derived from K562 cells after TKI discontinuation significantly improved the proliferation of MDSCs compared with MVs from before TKI discontinuation. The bidirectional interaction results in a vicious cycle, by providing a protective niche against immune attacks. Therapeutic interventions modulating this interaction might accelerate the success of TFR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available